top of page
How it Works?
Utilising proprietary screen of common human proteins, we are able to detect potential toxicology or other unexpected interactions that may fail the project downstream.
We apply machine learning and AI to match the 3D structure of an API (Active Pharmaceutical Ingredient) in development with the 3D structure of the target protein or molecule in the proposed mechanism of action.
Using extensive bio databases, including the European Bioinformatics Institute, for detailed comparisons of API and targeted diseased protein structures. We consistently achieve an extremely high efficacy rate across our core client channels.
bottom of page